Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 34

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

626

HTML

6335

Figures (1-6)

249

Tables (1-1)

204

Sum=7414

Publishing Process of This Article

Item

Count

Browse

1122

Download

935

Sum=2057

Sep 14, 2013 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 14, 2013; 19(34): 5706-5712
Published online Sep 14, 2013. doi: 10.3748/wjg.v19.i34.5706

Full Size Figure Download Figure

Figure 5 Proportion of patients who developed a flat scar after ulcer healing in both groups. PPI: Proton-pump inhibitor; RM: Rebamipide.

Citation: Takayama M, Matsui S, Kawasaki M, Asakuma Y, Sakurai T, Kashida H, Kudo M. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. World J Gastroenterol 2013; 19(34): 5706-5712
URL: https://www.wjgnet.com/1007-9327/full/v19/i34/5706.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i34.5706